Patient survey of the impact of toxicities with FOLFOX + Bevacizumab (BV) in 1st line metastatic colorectal cancer (MCRC) in the community oncology setting

2006

Stepanski E, Fortner BV, Burns C, Johns A, Kulig K, Schwartzberg LS